Share This Page
Drug Price Trends for NDC 42291-0073
✉ Email this page to a colleague
Average Pharmacy Cost for 42291-0073
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 42291-0073
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| ABIRATERONE ACETATE 500MG TAB | AvKare, LLC | 42291-0073-60 | 60 | 1579.15 | 26.31917 | 2023-09-22 - 2028-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for the Pharmaceutical Industry: A Comprehensive Overview
Introduction
The pharmaceutical industry is a complex and dynamic sector, influenced by a myriad of factors including regulatory changes, technological advancements, and market demand. This article will delve into the current state of the pharmaceutical market, focusing on key aspects such as drug coding, price transparency, and future projections.
Understanding the National Drug Code (NDC)
The National Drug Code (NDC) is a unique identifier assigned to each drug product by the FDA. It is a three-segment number that helps in tracking and identifying drugs, including finished, unfinished, and compounded drug products. The NDC Directory, updated daily, contains information on all drugs submitted to the FDA in structured product labeling (SPL) electronic listing files[1].
Drug Price Transparency
Drug price transparency has become a critical issue in recent years, with many states and countries implementing policies to address the rising costs of prescription drugs. For instance, Oregon's Prescription Drug Price Transparency Program requires pharmaceutical manufacturers, health insurers, and other entities to report specific pricing information. This program highlights the significant impact of drug prices on consumers, with 29% of Americans reporting that they do not take their medications as prescribed due to cost[2].
Global Price Disparities
The prices of prescription drugs vary significantly across different regions. In the U.S., the average price per unit is 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world. This disparity is partly due to the U.S. having a drug mix that skews towards more expensive compounds[4].
Market Trends and Growth
The biopharmaceutical and biotechnology sectors are experiencing rapid growth, driven by technological advancements and evolving regulatory frameworks. The biopharma market size was estimated to be over $400 billion in 2024, with a projected compound annual growth rate (CAGR) of 7.56% between 2024 and 2029. The biotech sector is also growing, with a market size of nearly $500 billion in 2020 and an estimated CAGR of 9.4% between 2021 and 2027[3].
Clinical Trial Innovations
Clinical trial designs are undergoing significant changes, with a shift towards more innovative and efficient study designs. This includes the use of precision medicine and AI/ML technologies to streamline the drug development process. These innovations are expected to continue shaping the pharmaceutical industry in 2025 and beyond[3].
Regulatory Landscape
The regulatory landscape for pharmaceuticals is evolving to keep pace with innovation. This includes changes in how clinical trials are conducted and the increasing focus on patient-centered care. Regulatory bodies are also working to improve transparency and accountability in drug pricing and development[3].
Impact of Price Increases
Price increases in the pharmaceutical industry can have profound effects on consumers. For example, a generic version of naproxen saw a 2,527% price increase between 2012 and 2021, highlighting the need for better transparency and regulatory oversight in the pharmaceutical supply chain[2].
Future Predictions
Several key predictions for the biopharma and biotech industries in 2025 include:
- Accelerated Clinical Trial Designs: More efficient and innovative clinical trial designs will become prevalent.
- Regulatory Evolution: Regulatory frameworks will continue to adapt to technological and scientific advancements.
- Precision Medicine: There will be a greater focus on precision medicine and personalized healthcare.
- AI/ML Integration: Artificial intelligence and machine learning will play a more significant role in drug development and clinical trials[3].
Case Study: Extended Phenytoin Sodium
To illustrate the complexities of drug pricing and market dynamics, let's consider the example of Extended Phenytoin Sodium (NDC: 42291-772-01). This drug, used for the treatment of certain types of seizures, is available in various formulations and is subject to the same market forces as other prescription drugs. The pricing of such drugs can be influenced by factors such as production costs, market demand, and regulatory requirements.
Pricing Considerations
The price of Extended Phenytoin Sodium, like other prescription drugs, is affected by the broader market trends mentioned earlier. For instance, the drug's price could be higher in the U.S. compared to other countries due to the disparities in drug pricing discussed above.
Market Projections
Given the overall growth in the pharmaceutical market and the specific trends in the biopharma and biotech sectors, it is likely that the demand for drugs like Extended Phenytoin Sodium will continue. However, the prices may be subject to fluctuations based on regulatory changes, competition, and technological advancements.
Key Takeaways
- Drug Coding and Transparency: The NDC system ensures that drugs are uniquely identified, and transparency programs help in understanding and regulating drug prices.
- Global Price Disparities: Drug prices vary significantly across regions, with the U.S. having notably higher prices.
- Market Growth: The biopharma and biotech sectors are experiencing rapid growth driven by technological and regulatory advancements.
- Innovative Clinical Trials: Clinical trial designs are becoming more efficient and innovative.
- Regulatory Evolution: Regulatory frameworks are adapting to keep pace with innovation.
FAQs
What is the National Drug Code (NDC) and its significance?
The National Drug Code (NDC) is a unique three-segment number assigned to each drug product by the FDA. It helps in identifying and tracking drugs, ensuring that each drug product can be distinguished from others.
Why are drug prices higher in the U.S. compared to other countries?
Drug prices in the U.S. are higher due to several factors, including a drug mix that skews towards more expensive compounds, higher production costs, and different regulatory environments.
How are clinical trial designs changing in the biopharma and biotech industries?
Clinical trial designs are shifting towards more innovative and efficient study designs, incorporating precision medicine and AI/ML technologies to streamline the drug development process.
What is the impact of price transparency programs on the pharmaceutical industry?
Price transparency programs help in providing accountability for prescription drug pricing by disclosing specific pricing information from manufacturers, insurers, and other entities, which can lead to better regulatory oversight and potentially more affordable drugs for consumers.
How do regulatory changes affect the pharmaceutical industry?
Regulatory changes can significantly impact the pharmaceutical industry by influencing how drugs are developed, approved, and priced. Evolving regulatory frameworks aim to keep pace with technological and scientific advancements, ensuring safer and more effective drugs.
Sources
- FDA's National Drug Code Directory - FDA
- Prescription Drug Price Transparency Results and Recommendations - Oregon's Drug Price Transparency Program
- 5 Predictions for the Biopharma and Biotech Industries in 2025 - TFS CRO
- International Market Size and Prices - ASPE Issue Brief
- Extended Phenytoin Sodium Label - DailyMed
More… ↓
